Back to top of page

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)

List of required information for application:

1. Project title

2. Project summary/abstract

3. Contact information for the primary investigator and co-investigators

4. Research plan/protocol for the diagnostic or therapeutic intervention

5. Description of the HLBS disorder being targeted

6. Rationale for the proposed intervention and its potential impact on patient outcomes

7. Description of the proposed clinical trial, including study design, participant eligibility criteria, and endpoints

8. Plans for recruitment and retention of study participants

9. Budget for the project, including a breakdown of estimated costs for preclinical activities, clinical trial start-up and implementation, and overall project timeline

10. Justification for the requested funding amount

11. Statement of institutional support and resources available for the project

12. Description of the team's experience and expertise in conducting phase I clinical trials and working with HLBS disorders

13. Plan for data management and analysis

14. Regulatory and ethical considerations, including any necessary approvals or permits already obtained or planned

15. Dissemination plan for sharing the results of the clinical trial

16. Any additional supporting documents or references relevant to the proposal.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows